Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues

Wound Repair and Regeneration

Volumn 17, Issue 5, 2009, Pages 750-757

  Rossiello, Luigi ^a   D'Andrea, Francesco ^a   Grella, Roberto ^a   Signoriello, Giuseppe ^a   Abbondanza, Ciro ^a   De Rosa, Caterina ^a   Prudente, Mariaevelina ^a   Morlando, Marianna ^a   Rossiello, Raffaele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ADOLESCENT; ADULT; ARTICLE; CELL INTERACTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS CELL; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; KELOID; MESENCHYME CELL; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHOOL CHILD; SKIN CELL; TISSUE DISTRIBUTION; WOUND HEALING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CICATRIX, HYPERTROPHIC; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KELOID; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 70349086463     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2009.00530.x     Document Type: Article

References (40)

1. Robles DT, Berg D. Abnormal wound healing: keloids. Clin Dermatol 2007 25 : 26 32.
2. Louw L. The keloid phenomenon: progress toward a solution. Clin Anatomy 2007 20 : 3 14.
3. Lee JY, Yang CC, Chao SC, Wong TW. Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol 2004 26 : 379 384.
4. Ghassan MS, Ladin D, Olson J, Han X, Hou Z, Fivenson D. Analysis of p53 gene mutation in keloids using polymerase chain reaction-based single-strand conformation polymorphism and DNA sequencing. Arch Dermatol 1998 134 : 963 967.
5. Marneros AG, Norris JE, Olsen BR, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol 2001 137 : 1429 1434.
6. Barrow RE, Dasu MRK. Oxidative and heat stress gene changes in hypertrophic scar fibroblasts stimulated with interleukin-1β. J Surg Res 2005 126 : 59 65.
7. 2. Burns 2006 32 : 299 304.
8. Ong CT, Khoo YT, Tan EK, Mukhopadhyay A, Do DV, Han HC, Lim IJ, Phan TT. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion. J Pathol 2007 211 : 95 108.
9. Khoo YT, Ong CT, Mukhopadhyay A, Han HC, Do DV, Lim IJ, Phan TT. Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast coculture contributes to keloid pathogenesis. J Cell Physiol 2006 208 : 336 343.
10. Bettinger DA, Yager DR, Diegelmann RF, Cohen IK. The effect of TGF-β on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996 98 : 827 833.
11. von Rahden BH, Brücher BL, Langner C, Siewert JR, Stein HJ, Sarbia M. Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor β1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine. Br J Surg 2006 93 : 1424 1432.
12. Rouzer CA, Marnett LJ. Structural and functional differences between cyclooxygenase: fatty acid oxygenase with a critical role in cell signalling. Biochem Biophys Res Commun 2005 338 : 34 44.
13. Kagoura M, Toyoda M, Matsui C, Morohashi M. Immunohistochemical expression of cyclooxygenase-2 in skin cancer. J Cut Pathol 2001 28 : 298 303.
14. Su JL, Shih JY, Yen ML, Jeng YM, Chang CC, Hsieh CY, Wei LH, Yang PC, Kuo ML. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor C up-regulation: a novel mechanisms of lymphoangiogenis in lung adenocarcinoma. Cancer Res 2004 64 : 554 564.
15. Rossiello L, Ruocco E, Signoriello G, Micheli P, Rienzo M, Napoli C, Rossiello R. Evidence of COX-1 and COX-2 expression in Kaposi's sarcoma tissues. Eur J Cancer 2007 43 : 1232 1241.
16. Funayama E, Chodon T, Oyama A, Sugihara T. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid. J Invest Dermatol 2003 121 : 1326 1331.
17. Bellemare J, Roberge CJ, Bergeron D, Lopez-Vallè CA, Roy M. Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars. J Pathol 2005 206 : 1 8.
18. Karrer S, Bossheroff AK, Weiderer P, Landthaler M. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol 2004 151 : 776 783.
19. Wilgus TA, Vodovotz Y, Vittadini E, Clubbs EA, Oberyszyn TM. Reduction of scar formation in full-thickness wounds with topical celecoxib treatment. Wound Repair Regen 2003 11 : 25 34.
20. Shibutani M, Uneyama C, Miyazaki K, Toyoda K, Hirose M. Methacarn fixation: a novel tool for analysis of gene expressions in paraffin-embedded tissue specimens. Lab Invest 2000 80 : 199 208.
21. Dejardin J, Kingston RE. Purification of protein associated with specific genomic loci. Cell 2009 136 : 175 186.
22. Leammli UK. Cleavage of structural proteins during assembly of the bacteriophage T4. Nature 1970 227 : 680 685.
23. Becker KF, Schott C, Hipp S, Metzger V, Porschewski P, Beck R, Nährig J, Becker I, Höfler H. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and monoscale molecular diagnosis. J Pathol 2007 211 : 370 378.
24. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor β in human disease. N Engl J Med 2000 342 : 1350 1358.
25. Companer AB, Ferreira LM, Gragnani A, Bruder JM, Cusik JL, Morgan JR. Upregulation of TGF-β1 expression may be necessary but is not sufficient for excessive scarring. J Invest Dermatol 2006 126 : 1168 1176.
26. Zhu G, Cai J, Zhang J, Zhao Y, Xu B. Abnormal nuclear factor (NF)-kB signal pathway and aspirin inhibits tumor necrosis factor α- induced NF-kB activation in keloid fibroblasts. Dermatol Surg 2007 33 : 697 708.
27. Leask A, Abraham DJ. TGF-β signaling and the fibrotic response. FASEB J 2004 18 : 816 827.
28. Diaz A, Chepenik K, Korn JH, Reginato AM, Jimenez SA. Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts. Exp Cell Res 1998 241 : 222 229.
29. Nirodi CS, Devalaraja R, Nanney LB, Arrindell S, Russell S, Trupin J, Richmond A. Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair Regen 2000 8 : 371 377.
30. Han C, Demetris AJ, Liu Y, Shelhamer JH, Wu T. Transforming growth factor β (TGF-β) activates cytosolic phospholipase A2α (cPLA2α)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-γ (PPAR-γ)/Smad signaling pathways in human liver cancer cells. A novel mechanism for subversion of TGF-β-induced mitoinhibition. J Biol Chem 2004 279 : 44344 44354.
31. McKee PH, Calonje E, Granter SR. Benign fibrous and myofibroblastic tumors. In : McKee PH, Calonie E, Granter SR. eds. Pathology of the skin, Vol. II. Philadelphia : Elsevier, 2005 : 1699 1723.
32. Atyeh BS, Costagliola M, Hayek SN. Keloid or hypertrophic scar: the controversy. Review of the literature. Ann Plast Surg 2005 54 : 676 680.
33. Burd A, Huang L. Hypertrophic response and keloid diathesis: two very different forms of scar. Plast Reconstr Surg 2005 116 : 150 157.
34. Lu F, Gao J, Ogawa R, Hyakusoki H. Variations in gap junctional intercellular communication and connexin expression in fibroblasts derived from keloid and hypertrophic scar. Plast Reconstr Surg 2007 119 : 844 851.
35. Lu F, Gao J, Ogawa R, Hyakusoku H, Ou C. Fas-mediated apoptotic signal transduction in keloid and hypertrophic scar. Plast Reconstr Surg 2007 119 : 1714 1721.
36. Tanaka A, Hatoko M, Tada H, Lioka H, Niitsuma K, Miyagawa S. Expression of p53 family in scars. J Dermatol Sci 2004 34 : 17 24.
37. Xia W, Phan TT, Lim IJ, Longaker MT, Yang GP. Differential transcriptional responses of keloid and normal keratinocytes to serum stimulation. J Surg Res 2006 135 : 156 163.
38. Materazzi S, Pellerito S, Di Serio C, Paglierani M, Naldini A, Ardinghi C, Carraro F, Geppetti P, Cirino G, Santucci M, Tarantini F, Massi D. Analysis of protease-activated receptor-1 and -2 in human scar formation. J Pathol 2007 212 : 440 449.
39. Yang GP, Lim IJ, Phan TT, Lorenz HP, Longaker MT. From scarless fetal wound to keloid: molecular studies in wound healing. Wound Repair Regen 2003 11 : 411 418.
40. Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, Stefanaki K, Argyrakos T, Petridis A, Katsambas A. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol 2005 52 : 474 479.